Vaccine for new COVID disease in 2025?
Ja
$10,256 Umsatz
$10,256 Umsatz
Dec 31, 2025
Regeln
On February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013)
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
Erstellt am: Feb 21, 2025, 4:48 PM ET
Volumen
$10,256Enddatum
Dec 31, 2025Erstellt am
Feb 21, 2025, 4:48 PM ETResolver
0x6A9D22261...Ergebnis vorgeschlagen: Nein
Kein Widerspruch
Endgültiges Ergebnis: Nein
Vaccine for new COVID disease in 2025?
Ja
$10,256 Umsatz
$10,256 Umsatz
Dec 31, 2025
Über
On February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013)
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
Volumen
$10,256Enddatum
Dec 31, 2025Erstellt am
Feb 21, 2025, 4:48 PM ETResolver
0x6A9D22261...Ergebnis vorgeschlagen: Nein
Kein Widerspruch
Endgültiges Ergebnis: Nein
Vorsicht vor externen Links.
Vorsicht vor externen Links.

Vorsicht vor externen Links.
Vorsicht vor externen Links.